Associated Papers
Molecular consequences of acute versus chronic CDK12 loss in prostate carcinoma nominates distinct therapeutic strategies.
Frank S et al.
Biorxiv : the Preprint Server for Biology, 2025
39071291 (PubMed )
Supplement: media-1.xlsx › OPX
Clinical sequencing identifies potential actionable alterations in a high rate of urachal and primary bladder adenocarcinomas.
Varadi M et al.
Cancer Medicine, 2023
36670542 (PubMed )
Supplement: CAM4-12-9041-s001.xlsx › QCI_-_UrC_-_Targeted
Select a paper to view details